Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News DRI Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

Healthcare
DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence... see more

Recent & Breaking News (TSX:DHT.UN)

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of Omidria® for Intracameral Use During Cataract Surgery or Intraocular Lens Replacement

Canada NewsWire October 3, 2022

DRI Healthcare Trust Provides Update on Natpara Royalty

Canada NewsWire October 3, 2022

DRI Healthcare (TSX:DHT.UN) acquires royalty for US$35M

Caroline Egan  September 12, 2022

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in Zejula®, Currently Approved for the Treatment of Ovarian Cancer with Additional Indications Under Development

Canada NewsWire September 12, 2022

DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

Canada NewsWire August 4, 2022

DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 4, 2022

Canada NewsWire July 21, 2022

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of pegcetacoplan Including Empaveli® /Aspaveli® for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

Canada NewsWire July 21, 2022

DRI Healthcare Trust Announces Voting Results of AGM

Canada NewsWire May 11, 2022

DRI Healthcare Trust Reports First Quarter 2022 Results

Canada NewsWire May 10, 2022

DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

Canada NewsWire April 27, 2022

DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 11, 2022

Canada NewsWire April 27, 2022

DRI Healthcare Trust Announces Upsized Credit Facility

Canada NewsWire April 20, 2022

DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2021 Results

Canada NewsWire March 7, 2022

DRI Healthcare (TSX:DHT.UN) secures FDA approval for drug candidate

Caroline Egan  March 1, 2022

DRI Healthcare Trust Comments on FDA Approval of VONJOTM (pacritinib)

Canada NewsWire March 1, 2022

DRI Healthcare Trust to Host Fourth Quarter Earnings Call and Webcast on March 8, 2022

PR Newswire February 22, 2022

DRI Healthcare Trust Declares Special Distributions

PR Newswire December 22, 2021

DRI Healthcare Trust Comments on Extension of Review Period for pacritinib

PR Newswire November 30, 2021

DRI Healthcare Trust Reports Third Quarter 2021 Results and Announces Increase to Quarterly Distribution

PR Newswire November 8, 2021

DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 9, 2021

PR Newswire October 25, 2021